Prawo i regulacje · 24/02/2020

Scottsdale Research Institute submits application to bulk manufacture controlled substances

The Scottsdale Research Institute has submitted an application to the U.S. Drug Enforcement Administration to become a bulk manufacturer of controlled substances, a move that could significantly expand its research capabilities and potentially impact the pharmaceutical industry.